Reply to Leder and Hodge  by Elder, James et al.
896 Letters to the Editor
Am. J. Hum. Genet. 64:896–897, 1999
Reply to Leder and Hodge
To the Editor:
On the basis of human leukocyte antigen (HLA) asso-
ciation studies, workers in the field of psoriasis have long
been aware that the HLA complex plays an important
role in determining psoriasis susceptibility. The question
has always been why many families appear not to show
linkage to HLA. We share in the pleasure of Drs. Leder
and Hodge (1999 [in this issue]) now that the genetics
of the HLA region in psoriasis is coming into sharper
focus.
The general agreement between Leder and Hodge’s
studies (Leder et al. 1998), our own work (Jenisch et al.
1998 and in press), and the recent studies of Trembath
et al. (1997) and Burden et al. (1998) provides welcome
insight into this long-standing puzzle. By optimizing
LOD scores over a variety of penetrance functions, as-
suming Hardy-Weinberg equilibrium, Leder and Hodge
(Leder et al. 1998) found the highest LOD scores for
dominant models specifying high disease allele frequency
and low penetrance. We reached essentially the same
conclusion, following the suggestions of Risch et al.
(1989) for complex-trait data. It is well appreciated that
power to detect linkage is diminished when the disease
allele frequency is high and the penetrance is low. Given
the smaller sample sizes of earlier studies, it is not sur-
prising that linkage to the HLA region was not always
apparent.
We have reported that linkage to HLA is more readily
detected when marker-trait disequilibrium is taken into
account, in part because of more-accurate specification
of phase (Jenisch et al. 1998). Leder et al. (1998) and
Trembath et al. (1997) report similar results. This effect
was first pointed out 15 years ago (Clerget-Darpoux
1982) but has not been widely exploited in the genetic
analysis of other common HLA-associated disorders.
Even without incorporation of disease-marker haplotype
frequencies, Leder et al. (1998) found strong evidence
for linkage to HLA under a dominant model, whereas
we did not. Leder et al.’s study made use of previously
published pedigrees, and concerns regarding ascertain-
ment bias in favor of linkage are inevitable in such a
study. However, it is also possible that our sample
yielded lower LOD scores because it contained a number
of small pedigrees, thereby increasing the number of
phase-unknown individuals.
We concur with Leder and Hodge (1999) that there
is now excellent agreement regarding the importance of
the HLA region in familial psoriasis and that this locus
should now be referred to as PSORS1. We would em-
phasize that, because the HLA loci yielding the highest
LOD scores in familial psoriasis are so similar to those
observed in prior case-control association studies, there
is unlikely to be any difference between familial and
“sporadic” juvenile-onset psoriasis with respect to the
involvement of PSORS1. We can also infer that genetic
differences between juvenile- and adult-onset psoriasis
must exist, because of their different HLA associations
(Henseler and Christophers 1985). Whether an HLA lo-
cus different from PSORS1 is involved in the adult-onset
form of this disease remains to be determined.
High disease allele frequencies and low penetrance
values are likely to be the rule rather than the exception
in common multifactorial diseases. We hope that these
recent insights into the genetics of the HLA region in
psoriasis will be of benefit to other groups studying com-
plex genetic disorders.
JAMES ELDER,1 RAJAN NAIR,1 PHILIP STUART,1
JOHN VOORHEES,1 SUN-WEI GUO,2 STEFAN JENISCH,3
ECKHARD WESTPHAL,3 MARTIN KRO¨NKE,3
TILO HENSELER,4 AND ENNO CHRISTOPHERS4
1Department of Dermatology, University of Michigan,
Ann Arbor; 2Institute of Human Genetics and
Division of Epidemiology,University of Minnesota,
Minneapolis; and Departments of 3Immunology and
4Dermatology, University of Kiel, Kiel, Germany
References
Burden AD, Javed S, Bailey M, Hodgins M, Connor M, Till-
man D (1998) Genetics of psoriasis: paternal inheritance and
a locus on chromosome 6p. J Invest Dermatol 110:958–960
Clerget-Darpoux F (1982) Bias of the estimated recombination
fraction and LOD score due to an association between a
disease gene and a marker gene. Ann Hum Genet 46:
363–372
Henseler T, Christophers E (1985) Psoriasis of early and late
onset: characterization of two types of psoriasis vulgaris. J
Am Acad Dermatol 13:450–456
Jenisch S, Henseler T, Nair RP, Guo S-W, Westphal E, Stuart
P, Kro¨nke M, et al (1998) Linkage analysis of HLA markers
in familial psoriasis: strong disequilibrium effects provide
evidence for a major determinant in the HLA-B/-C region.
Am J Hum Genet 63:191–199
Jenisch S, Westphal E, Nair RP, Stuart P, Voorhees JJ, Chris-
tophers E, Kro¨nke M, et al. Linkage disequilibrium analysis
of familial psoriasis: identification of multiple disease-as-
sociated MHC haplotypes. Tissue Antigens (in press)
Leder RO, Hodge SE (1999) Psoriasis linkage in the HLA
region. Am J Hum Genet 64:895–895 (in this issue)
Leder RO, Mansbridge JN, Hallmayer J, Hodge SE (1998)
Familial psoriasis and HLA-B: unambiguous support for
linkage in 97 published families. Hum Hered 48:198–211
Risch N, Claus E, Giuffra L (1989) Linkage and mode of
inheritance in complex traits. Prog Clin Biol Res 329:
183–188
Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp
Letters to the Editor 897
Figure 1 Composite nucleotide sequence showing RP2 exons,
including the coding region, and the exon-intron boundaries. Thenum-
bers on the right refer to the amino acid residues of the predicted RP2
protein.
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Protein-Truncation Mutations in the RP2 Gene in a
North American Cohort of Families with X-Linked
Retinitis Pigmentosa
To the Editor:
X-linked forms of retinitis pigmentosa (XLRP) are a ge-
netically heterogeneous group of retinal dystrophies that
result in relatively severe clinical manifestations (Bird
1975; for a review, see Aldred et al. 1994). The two
major XLRP loci, RP2 (MIM 312600) and RP3 (MIM
312610), have been mapped to Xp11.32-11.23 and
Xp21.1, respectively (for a review see Aldred et al. 1994;
Fujita et al. 1996; Fujita and Swaroop 1996; Thiselton
et al. 1996). The RP15 locus (MIM 300029) has been
mapped to Xp22.13-22.11 in a single family with retinal
degeneration (McGuire et al. 1995), and some evidence
exists for a fourth locus, RP6 (MIM 312612), at Xp21.3
(Musarella et al. 1990; Ott et al. 1990). We recently
localized another genetic locus, RP24 (MIM 300155),
at Xq26-27 by using linkage analysis in an XLRP family
(Gieser et al. 1998). In addition, the disease in some
retinitis pigmentosa (RP) families with apparently X-
linked inheritance does not seem to be linked to markers
in the region of mapped XLRP loci (Teague et al. 1994;
L. Gieser, R. Fujita, and A. Swaroop, unpublished data).
It therefore appears that mutations in several genes on
the X chromosome may lead to RP.
The first XLRP gene, RPGR (retinitis pigmentosa
GTPase regulator), was isolated from the RP3 region
(Meindl et al. 1996; Roepman et al. 1996). Genetic anal-
ysis has suggested that RP3 accounts for 70% of XLRP
(Ott et al. 1990; Teague et al. 1994; Fujita et al. 1997).
However, RPGR mutations are detected in only 20% of
XLRP (and genetically defined RP3) families (Buraczyn-
ska et al. 1997; Fujita et al. 1997; M. Guevara-Fujita,
S. Fahrner, and A. Swaroop, unpublished data). TheRP2
gene has recently been isolated by a positional cloning
strategy (Schwahn et al. 1998) and is predicted to encode
a protein of 350 amino acids with homology to cofactor
C, which is involved in folding of b-tubulin (Tian et al.
1996). TheRP2 locus is believed to represent 20%–30%
of XLRP in Europe (Ott et al. 1990; Teague et al. 1994),
but little or no genetic evidence exists for anRP2 subtype
in the XLRP families from North America (Musarella
et al. 1990; Ott et al. 1990). Because our haplotype
analysis provided suggestive evidence for RP2 in two
North American families (R. Fujita, L. Gieser, S. G. Ja-
cobson, P. A. Sieving, and A. Swaroop, unpublished
data), we examined the genomic DNA from our cohort
of XLRP patients for causative mutations in the RP2
gene.
The procedures for clinical ascertainment of patients,
obtaining blood samples, and preparation of genomic
DNA have been reported elsewhere (Fujita et al. 1997).
The families included in the present study showed an
apparent X-linked inheritance and no male-to-male
transmission. Affected male individuals had a clinical
